Fertility is one of the most important aspects of a woman's life, especially for those planning a pregnancy or undergoing in-vitro fertilization (IVF). One of the most reliable hormone tests to evaluate ovarian reserve is the AMH (Anti-Müllerian Hormone) test.

AMH is a hormone produced by the follicle cells in the ovaries and reflects the number of remaining egg reserves in a woman. The higher the AMH level, generally the better the fertility potential, although it does not always correlate with natural pregnancy chances. Conversely, a low AMH level can signal declining ovarian reserve and possible proximity to menopause.

AMH testing is highly recommended for:

• Women experiencing infertility or undergoing a fertility program
• Couples undergoing IVF procedures
• Women with a family history of early menopause
• Cancer patients undergoing chemotherapy or radiotherapy
• Women with PCOS or those who have had ovarian surgery

One major advantage of the AMH test is its flexibility. It does not require fasting, is not affected by the menstrual cycle, and can be done anytime without special preparation. With just one blood sample, doctors can gain a strong overview of the patient’s ovarian reserve.

Clinically, AMH testing is also useful for:

• Planning ovulation stimulation strategies in fertility programs
• Determining the ideal number of embryos for transfer
• Preventing ovarian hyperstimulation syndrome (OHSS)
• Evaluating the impact of cancer therapy on reproductive function

AMH is more than just a number—it is valuable information that can help Sahabat PRAMITA take the right medical steps with confidence. For those pursuing the dream of parenthood, this test could be the beginning of hope.